Stanford University


Showing 171-180 of 620 Results

  • Lawrence Fung MD PhD

    Lawrence Fung MD PhD

    Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)

    Current Research and Scholarly InterestsDr. Lawrence Fung is a physician-scientist specializing in autism and neurodiversity. Dr. Fung is an associate professor of Psychiatry at Stanford University. He is the director of the Stanford Neurodiversity Project (SNP), director of the Neurodiversity Clinic, and PI at the Fung Lab. Dr. Fung’s research traverses from multi-modal neuroimaging studies to a new conceptualization of neurodiversity and its application to clinical, educational, and employment settings. His lab has two main arms of research: (1) neurobiology of autism and (2) neurodiversity.
    The neurobiology arm of his lab focuses on advancing the understanding of the thalamocortical circuits and their socio-communicative and cognitive functions in people on the spectrum by using novel neuroimaging and bioanalytical technologies. The findings of his neurobiology research efforts were published in top journals in our field, such as Molecular Psychiatry, Translational Psychiatry, and Psychoneuroendocrinology.
    Using a community-based participatory research approach, Dr. Fung’s team devises and implements novel interventions to improve the lives of neurodiverse individuals by maximizing their potential and productivity. He has developed and assessed several psychoeducational interventions, including the Developing Inclusive and Vocational Educational Resources for Success and Employment (DIVERSE) curriculum.
    Dr. Fung is also the founding director of the SNP, a special initiative of the Department of Psychiatry at Stanford. Since 2017, the SNP has organized various events, including the Stanford Neurodiversity Summit, which brings thousands of people together yearly to share visions, innovations, and inspirations about maximizing the potential of neurodiversity. Each summer, about 100 high-school students join us at the SNP’s Research, Education, and Advocacy Camp for High Schoolers (SNP-REACH), to learn how to develop neurodiversity advocacy projects. Dr. Fung also teaches a neurodiversity design thinking course at Stanford. Clinically, Dr. Fung has applied the SBMN to his clinical work and is teaching a CME course focusing on delivering neurodiversity-affirmative care to neurodivergent patients.

  • Joseph Garner

    Joseph Garner

    Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.

  • Grace Gengoux, PhD, BCBA-D

    Grace Gengoux, PhD, BCBA-D

    Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    Current Research and Scholarly InterestsDr. Grace Gengoux is Director of the Autism Intervention Clinic and leads an autism intervention research program focused on developing and evaluating promising behavioral and developmental treatments for Autism Spectrum Disorder (ASD).

    Dr. Gengoux is also Associate Chair for Faculty Engagement & Well-being and Department Well-being Director in the Department of Psychiatry and Behavioral Sciences, leading the department's Standing Well-being Advisory Committee.

  • Luciana Giambarberi, MD

    Luciana Giambarberi, MD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Giambarberi is a double-board-certified physician who completed her general psychiatry residency training at Wake Forest University School of Medicine and her Behavioral Neurology and Neuropsychiatry (BNNP) fellowship training at Stanford University School of Medicine. Her past experience includes leading, creating, expanding, and providing neuropsychiatry education and care to communities across the southeast region.

    As a clinical associate professor in the Department of Psychiatry at Stanford, Dr. Giambarberi supervises trainees in the Neuropsychiatry Section and the Individual Psychotherapy Clinic. Dr. Giambarberi's administrative duties include serving as director of the Movement Disorders Clinic and director of BNNP didactics, as well as overseeing neurology core rotations and elective rotations within the neuropsychiatry section.

    Dr. Giambarberi has extensive clinical experience with a diverse neuropsychiatric patient population, and her research is primarily grounded in education. She is also an active member and contributor to national and international neuropsychiatric organizations.


    ***For clinic appointment requests and referrals, please call 650-498-9111.

  • William Giardino

    William Giardino

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsWe aim to decipher the neural mechanisms underlying psychiatric conditions of stress, addiction, and sleep/circadian dysregulation. Our work uses combinatorial technologies for precisely mapping, monitoring, and manipulating neural circuits that regulate emotional states. We are especially focused on the behavioral functions of neuropeptide molecules acting throughout the circuitry of the extended amygdala- particularly in a brain region called the bed nucleus of the stria terminalis (BNST).

  • Erin Gibson

    Erin Gibson

    Assistant Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)

    Current Research and Scholarly InterestsGlia make up more than half of the cells in the human brain, but we are just beginning to understand the complex and multifactorial role glia play in health and disease. Glia are decidedly dynamic in form and function. Understanding the mechanisms underlying this dynamic nature of glia is imperative to developing novel therapeutic strategies for diseases of the nervous system that involve aberrant gliogenesis, especially related to changes in myelination.